RAPT Therapeutics Inc (RAPT)
1.38
-0.19
(-12.10%)
USD |
NASDAQ |
Nov 14, 12:06
RAPT Therapeutics Total Liabilities (Quarterly): 17.96M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.96M |
| March 31, 2024 | 24.98M |
| December 31, 2023 | 26.29M |
| September 30, 2023 | 26.92M |
| June 30, 2023 | 21.08M |
| March 31, 2023 | 27.86M |
| December 31, 2022 | 21.04M |
| September 30, 2022 | 20.18M |
| June 30, 2022 | 19.86M |
| March 31, 2022 | 19.71M |
| December 31, 2021 | 12.26M |
| September 30, 2021 | 15.59M |
| Date | Value |
|---|---|
| June 30, 2021 | 13.50M |
| March 31, 2021 | 14.28M |
| December 31, 2020 | 14.79M |
| September 30, 2020 | 18.92M |
| June 30, 2020 | 17.06M |
| March 31, 2020 | 18.96M |
| December 31, 2019 | 11.48M |
| September 30, 2019 | 183.17M |
| June 30, 2019 | 8.103M |
| March 31, 2019 | 173.61M |
| December 31, 2018 | 166.72M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.48M
Minimum
Dec 2019
27.86M
Maximum
Mar 2023
19.09M
Average
18.96M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 33.55M |
| GlycoMimetics Inc | 4.356M |
| FibroGen Inc | 483.58M |
| Cidara Therapeutics Inc | 42.42M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.18M |
| Shareholders Equity (Quarterly) | 109.22M |